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Initial Evaluation of Adolescent Females Hospitalized with Heavy Menstrual Bleeding
Lauren E. Amos, MD¹, Shannon L. Carpenter, MD, MS¹
¹Division of Hematology-Oncology-BMT, Children’s Mercy Hospital, Kansas City, Missouri
Background: Heavy menstrual bleeding (HMB) in adolescents can be severe and life-threatening. Up to
30% of young women who are hospitalized with anemia due to HMB have a bleeding disorder.
Guidelines from the American College of Obstetrics and Gynecology (ACOG) and the National Heart,
Lung, and Blood Institute (NHLBI) recommend evaluation for bleeding disorders in such patients. ACOG
recommendations include testing for von Willebrand disease (VWD) and specify that consultation with a
hematologist may help in interpreting results. NHLBI recommends testing for vWD be done in
conjunction with a hematologist. ACOG guidelines do not include testing for platelet function disorders
(PFD). Early and accurate diagnosis of bleeding disorders is important, yet limited data exists on the
diagnostic evaluation for bleeding disorders in adolescent females hospitalized for HMB.
Objective: To evaluate the diagnostic evaluation of bleeding disorders in adolescent females hospitalized
for HMB.
Methods: A retrospective, single center chart review of female patients aged 9-21 years hospitalized for
HMB and anemia at a tertiary care children’s hospital from January 1, 2000 until December 31, 2017 was
done. Patients were identified from our Hemophilia Treatment Center (HTC) registry, review of patients
seen at a comprehensive clinic staffed by pediatric hematologists and gynecologists, and by an
Electronic Medical Record (EMR) query of admission and discharge diagnoses of HMB and anemia. Data
obtained included clinical features, diagnostic evaluation, and laboratory results.
Results: 118 patients hospitalized for HMB and anemia were included. Inpatient Hematology consult or
outpatient referral occurred in 68 (58%) of the patients; 60/68 (88%) had a bleeding disorder evaluation
completed. 34 patients had a hematologic disorder. PFD was the most common (15/34; 44%) followed
by VWD (9/34; 26%). 42% (50/118) of the patients did not have a Hematology consult or outpatient
referral (Table 1). While hospitalized for HMB and anemia, 29 of the 50 patients had testing for vWD
performed and only 4/29 (14%) had testing repeated as an outpatient once hemoglobin normalized. No
patients tested for VWD while inpatient had results consistent with the diagnosis. Platelet function
testing was performed in 10/50 patients using the platelet function analyzer (PFA-100) in 8 patients and
platelet aggregometry in 2 patients.
Conclusions: Despite national guidelines and the presence of known risk factors for bleeding disorders,
the hematology service was not involved in the diagnostic process for a significant number of adolescent
females. In these patients, testing often occurred while patients were hospitalized and was not
repeated. Testing for platelet function disorders occurred infrequently and mainly consisted of the PFA100 which lacks sensitivity and specificity. When patients were evaluated by Hematology and tested for
bleeding disorders, a large proportion had a bleeding disorder, of which PFD were most common. This
study demonstrates the need for standardization of the evaluation of adolescent females hospitalized

for HMB. Guidelines should be updated to include testing for PFD. Hematologists should be involved
when females are hospitalized for HMB and anemia.

